Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Rheumatology
Volume 2017, Article ID 5386797, 6 pages
https://doi.org/10.1155/2017/5386797
Case Report

Effective Administration of Rituximab in Anti-MDA5 Antibody–Positive Dermatomyositis with Rapidly Progressive Interstitial Lung Disease and Refractory Cutaneous Involvement: A Case Report and Literature Review

1Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto 390-8621, Japan
2Department of Dermatology, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto 390-8621, Japan

Correspondence should be addressed to Yasuhiro Shimojima; pj.ca.u-uhsnihs@ijomihsy

Received 31 July 2017; Accepted 24 September 2017; Published 31 October 2017

Academic Editor: Gregory J. Tsay

Copyright © 2017 Yuka Ogawa et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Yuka Ogawa, Dai Kishida, Yasuhiro Shimojima, Koichi Hayashi, and Yoshiki Sekijima, “Effective Administration of Rituximab in Anti-MDA5 Antibody–Positive Dermatomyositis with Rapidly Progressive Interstitial Lung Disease and Refractory Cutaneous Involvement: A Case Report and Literature Review,” Case Reports in Rheumatology, vol. 2017, Article ID 5386797, 6 pages, 2017. https://doi.org/10.1155/2017/5386797.